Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard D Thames

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysisMichael E Ray, Howard D Thames, Larry B Levy, et al.
Cancer|September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
Journal of the National Cancer Institute|November 18, 2004
Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patientsTse-Kuan Yu, Gary J Whitman, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban, Howard D Thames, Larry B Levy, et al.
Cancer|January 9, 2003
Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinomaChristopher H Crane, John M Skibber, Barry W Feig, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fieldsKaren H Shahar, Kelly K Hunt, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groupsHoward D Thames, Deborah A Kuban, Michelle L DeSilvio, et al.
The Journal of Urology|February 16, 2005
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysisEric M Horwitz, Howard D Thames, Deborah A Kuban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisRanda Tao, Sunil Krishnan, Priya R Bhosale, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2023
Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer centerAlan J Sosa, Howard D Thames, Jeremiah W Sanders, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|October 4, 2005
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysisMichael E Ray, Howard D Thames, Larry B Levy, et al.
Cancer|September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
Journal of the National Cancer Institute|November 18, 2004
Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patientsTse-Kuan Yu, Gary J Whitman, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban, Howard D Thames, Larry B Levy, et al.
Cancer|January 9, 2003
Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinomaChristopher H Crane, John M Skibber, Barry W Feig, et al.
International Journal of Radiation Oncology, Biology, Physics|July 6, 2004
Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fieldsKaren H Shahar, Kelly K Hunt, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groupsHoward D Thames, Deborah A Kuban, Michelle L DeSilvio, et al.
The Journal of Urology|February 16, 2005
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysisEric M Horwitz, Howard D Thames, Deborah A Kuban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response AnalysisRanda Tao, Sunil Krishnan, Priya R Bhosale, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2023
Proton therapy for the management of localized prostate cancer: Long-term clinical outcomes at a comprehensive cancer centerAlan J Sosa, Howard D Thames, Jeremiah W Sanders, et al.
Pageof 8